Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Melincoff Gwen A, Director. Insider active across 2 companies, notably COLLEGIUM PHARMACEUTICAL, INC. Cumulatively, 5 disclosures have been logged. History available since 20 May 2021. The latest transaction was filed on 16 May 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Gwen A. Melincoff is a Board Member at COLLEGIUM PHARMACEUTICAL, INC. She has a strong background in corporate governance and strategy, playing a key role in the strategic direction of the organization. Her role involves overseeing operations and ensuring that governance practices are upheld.